middle.news
How Memphasys Is Scaling Felix™ Globally with New MENA Deal and Cost Cuts
10:11am on Friday 31st of October, 2025 AEDT
•
Biotechnology
Read Story
How Memphasys Is Scaling Felix™ Globally with New MENA Deal and Cost Cuts
10:11am on Friday 31st of October, 2025 AEDT
Key Points
Exclusive five-year ITL distribution deal expanded to 15 MENA countries including Turkey
Manufacturing cost reduction program targeting under $40 per Felix™ cartridge
CE Mark regulatory approval expected early 2026 to unlock EU and Australian markets
Operational costs reduced by approximately 40%, reallocating capital to commercial execution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE